Oxidative stress, inflammation and carcinogenesis are controlled through the pentose phosphate pathway by transaldolase
about
The regulation of the oxidative phase of the pentose phosphate pathway: new answers to old problemsmTOR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and agingProteomic analysis of mesenchymal stem cells from normal and deep carious dental pulp.The functional O-mannose glycan on α-dystroglycan contains a phospho-ribitol primed for matriglycan additionLiver injury correlates with biomarkers of autoimmunity and disease activity and represents an organ system involvement in patients with systemic lupus erythematosus.Transaldolase Deficiency: A New Case Expands the Phenotypic Spectrum.Oxidative stress in the pathology and treatment of systemic lupus erythematosusTransaldolase deficiency: report of 12 new cases and further delineation of the phenotype.Pulmonary manifestations in a patient with transaldolase deficiency.Aerobic glycolysis in osteoblasts.Functional analysis of the molecular interactions of TATA box-containing genes and essential genes.Oncogenic viruses and tumor glucose metabolism: like kids in a candy store.The return of metabolism: biochemistry and physiology of the pentose phosphate pathwayA ROS-Activatable Agent Elicits Homologous Recombination DNA Repair and Synergizes with Pathway CompoundsComprehensive metabolome analyses reveal N-acetylcysteine-responsive accumulation of kynurenine in systemic lupus erythematosus: implications for activation of the mechanistic target of rapamycinEvidence for transaldolase activity in the isolated heart supplied with [U-13C3]glycerol.Transketolase counteracts oxidative stress to drive cancer development.Antioxidant function of isoflavone and 3,3'-diindolylmethane: are they important for cancer prevention and therapy?Mitochondrial dysfunction induces formation of lipid droplets as a generalized response to stress.Mitochondrial Dysfunction in the Liver and Antiphospholipid Antibody Production Precede Disease Onset and Respond to Rapamycin in Lupus-Prone Mice.Altered DNA methylation associated with an abnormal liver phenotype in a cattle model with a high incidence of perinatal pathologies.Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases.The Amazing Power of Cancer Cells to Recapitulate Extraembryonic Functions: The Cuckoo's Tricks.Effect of mitochondrial uncoupling and glycolysis inhibition on ram sperm functionality.Network Analysis Identifies Disease-Specific Pathways for Parkinson's Disease.Immunometabolism in systemic lupus erythematosus.T cells display mitochondria hyperpolarization in human type 1 diabetes.PharmGKB summary: methylene blue pathway.Polyol accumulation in muscle and liver in a mouse model of type 2 diabetes.Association between SOD2 C47T polymorphism and lung cancer susceptibility: a meta-analysis.Uncovering the beginning of diabetes: the cellular redox status and oxidative stress as starting players in hyperglycemic damage.Review: Metabolic Control of Immune System Activation in Rheumatic Diseases.Cytotoxicity of portoamides in human cancer cells and analysis of the molecular mechanisms of action.In Vitro-In Vivo Dose Response of Ursolic Acid, Sulforaphane, PEITC, and Curcumin in Cancer Prevention.Characterization of urinary extracellular vesicle proteins in muscle-invasive bladder cancer.Metabolic changes in the liver of mice with Ehrlich ascites carcinoma.Extracellular Vesicles in Bladder Cancer: Biomarkers and Beyond
P2860
Q27003280-A3E1516C-804F-4D6C-BC81-97FDE1B05F97Q28081442-240003A7-C948-456F-A9F4-F2962E8932F1Q31160753-14AE1B35-4A53-4E68-A294-E8B3DD440B4CQ32884479-E08CB34F-3D53-419C-8FBE-5AF4FB8E8FBDQ33424303-04788A34-6269-4619-AD16-62FD9439AE67Q33424896-2D1721BD-753E-483E-B5F1-D499E75B6439Q33715508-B486541D-0473-4EE9-81A1-E8953B75D9F0Q34322321-C8BC0BE8-2906-4683-BB74-49FC467728E2Q34357050-0DDFB788-ECCA-49E0-A137-09E4BCC2A041Q34437563-F84DBE61-5573-43E1-BBB5-536D2531605BQ35581121-EE3E77E7-FAD1-401D-A5AF-DEFD7B28E48AQ35671327-44AF434B-95DE-4104-9E03-41AEA508FBC1Q35752267-9851AFFD-FAA1-4A47-84E0-58EDD036B911Q35792527-28EE4F7E-E026-408C-9F6B-5A538A26A306Q36024179-E9704138-00DF-4A6D-92A9-6CBDE42601E7Q36579417-41743C3F-83C1-4CA7-A1B4-C5BDB438ADCEQ36598816-88C053A8-9F54-48A4-BD8B-2DCC6AF7E33AQ36945706-BAC1001C-72BA-41B9-96E5-51D925B89D75Q37224850-01A29EF2-0409-4190-82E6-291A48958D2DQ37372436-79EBEBD0-A370-436D-83AD-374312756414Q37497610-479533F1-AAD9-4BD3-80CB-BAC774F1049EQ37649641-7F9F8CCA-014F-4AD5-BF33-8BA6515FF949Q38586078-366A4CF6-5090-4064-95F8-352D6D338ACBQ39036847-2188E5FF-B078-410D-8BE1-A8A5412B3FE4Q39076065-97CB674C-7056-4411-A53F-E6A53CA6350DQ39209701-1C53E0BE-D1D9-4035-B5CB-491F93F74945Q41545654-3DDA7933-F351-49ED-AAF2-01C7044A83A9Q41890556-F0ACA756-AECA-4786-97C1-5494BC1A0D68Q42414753-B2E86028-4E02-4CA6-B3CA-FCDA79617471Q43641445-A27723E0-2D07-4BEB-9C61-8C0CAB3E73B8Q44314505-9F3978C1-032C-4F40-B80E-8D91831EBF73Q47133379-4FF29B61-36F7-4020-84E8-F8E9C0E140A7Q47147870-CBAEAB7D-A136-442C-9126-2DC002500301Q47271539-38CF84E3-D7D4-4D9D-B7B5-A41E4CCA9169Q47327779-E50C3048-BEEC-4C8C-A20A-0A8F5F19B1FDQ53008969-67809EF9-F7E6-46D3-B7BD-7DBF05FF6318Q58722406-D86E7A26-6BC4-4593-B055-693ADCCA6206
P2860
Oxidative stress, inflammation and carcinogenesis are controlled through the pentose phosphate pathway by transaldolase
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Oxidative stress, inflammation ...... phate pathway by transaldolase
@en
type
label
Oxidative stress, inflammation ...... phate pathway by transaldolase
@en
prefLabel
Oxidative stress, inflammation ...... phate pathway by transaldolase
@en
P2093
P2860
P1476
Oxidative stress, inflammation ...... phate pathway by transaldolase
@en
P2093
Robert Hanczko
Steve Landas
Tiffany Telarico
Zachary Oaks
P2860
P304
P356
10.1016/J.MOLMED.2011.01.014
P50
P577
2011-03-02T00:00:00Z